model 661 words KG: App 2026-03-31
kind:modelsection:modelsdisease:alzheimersspecies:mousemodel-type:transgenic
Contents

APP/PS1 Dual Transgenic Mouse Model

Knowledge Graph

Related Hypotheses (5)

Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa
Score: 0.70
Selective Cholinergic Protection via APP Pathway Modulation
Score: 0.43
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57

Related Analyses (9)

CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived

Related Experiments (24)

Plasma ATN biomarkers across AD continuum in Chilean cohort
clinical · proposed · Score: 0.95
Creation and validation of 3xAD-ChAT-Cre mouse model
validation · proposed · Score: 0.90
Adoptive transfer of TCRAβ-Tregs in AD mouse model
validation · proposed · Score: 0.90
Chi3l1 deletion in APP/PS1 mouse model of Alzheimer's diseas
validation · proposed · Score: 0.95
Anti-ASC antibody intracerebroventricular injection in APP/P
validation · proposed · Score: 0.95

Knowledge Graph (12 edges)

App inhibits Epilepsy
App biomarker_for Neurodegeneration
App biomarker_for Cancer
App biomarker_for Neuroinflammation
App therapeutic_target Fibrosis
App interacts_with Stroke
App interacts_with Atherosclerosis
App therapeutic_target Epigenetic
App therapeutic_target Amyotrophic Lateral Sclerosis
App therapeutic_target Multiple Sclerosis